L. Casei DG® in Patients With Irritable Bowel Syndrome.

Clinical Trial Summary

To assess the effect of L. casei DG® (Lactobacillus paracasei CNCMI1572; Enterolactis® plus) on abdominal symptoms and gut microbiota metabolism/composition in non constipated patients with IBS (Irritable Bowel Syndrome). Patients will be randomized to receive L. casei DG® capsules, b.i.d. for 12 weeks the a 4 weeks Follow Up period will follow.

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05118243` - Innovative Tools to Produce Legume-based Foods for Increased Consumer Acceptance	N/A
Completed	`NCT04422327` - The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome	Phase 1/Phase 2
Recruiting	`NCT05178017` - Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)	N/A
Completed	`NCT05197413` - Study to Evaluate the Efficacy of Arrae's Bloat & Calm Alchemy Capsules to Reduce Bloating, Heartburn and Gas, and Alleviate the Intensity of IBS Symptoms	N/A
Completed	`NCT04905524` - Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)	N/A
Recruiting	`NCT06297785` - Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS)	N/A
Recruiting	`NCT05874830` - The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome	N/A
Active, not recruiting	`NCT04723056` - Zemedy Application for Irritable Bowel Syndrome	N/A
Completed	`NCT05565612` - Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome	N/A
Recruiting	`NCT03131414` - The IMAGINE-SPOR CIHR Chronic Disease Network
Completed	`NCT03333291` - Fecal Transplantation in Patients With IBS	N/A
Recruiting	`NCT06215222` - Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
Completed	`NCT05016596` - Postprandial Lipids in IBS and Nutritional Treatment	N/A
Recruiting	`NCT04760353` - The Effect of a Probiotic Mixture in Obese Patients With Irritable Bowel Syndrome	N/A
Completed	`NCT06426745` - Split-dose Versus Single-dose Bowel Preparation for Colonoscopy	N/A
Recruiting	`NCT04217733` - Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome	Phase 3
Completed	`NCT03178877` - The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors	N/A
Recruiting	`NCT05990764` - Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS)	N/A
Completed	`NCT03948854` - Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients	N/A
Completed	`NCT04898257` - Effect of Lactibiane Tolerance® to Treat Leaky Gut in Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)Patients	N/A

NCT number	NCT03449628
Study type	Interventional
Source	SOFAR S.p.A.
Contact
Status	Completed
Phase	N/A
Start date	November 6, 2017
Completion date	December 30, 2021

L. Casei DG® in Patients With Irritable Bowel Syndrome. — PROBE2

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms